In contrast with other tumor types such as cervical cancer or glioblastoma multiforme, elevated IDO expression is considered a good prognostic factor for RCC patients since they show higher sensitivity to immunotherapies [47]. This evidence concerns the gene IDO1 and glioblastoma.